Carolina BioOncology Institute; Can Therapy & Res Ctr

Huntersville, North Carolina 28078

0 studies enrolling now · 3 studies all time

What they study most

Cancer, Hematologic Malignancies, Non-Small Cell Lung Cancer, Tumors

Studies at this site

• A Study of Atezolizumab Administered in Combination With Bevacizumab and/or With Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors — Completed
• A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR] — Completed
• A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors — Completed